Russia's 'Ghost Fleet' of Oil Ships Face New Round of EU Sanctions
The Chiefs are signing free agent left tackle D.J. Humphries, according to multiple reports. Ian Rapoport of NFL Media reports that the Chiefs are paying him up to $4.5 million for the rest of the season. Humphries is medically cleared to return to play after recovering from a torn ACL in Week 17 of last year. He visited the Giants in October, but they didn’t offer him a contract. Humphries, 30, spent his first nine seasons with the Cardinals after they made him a first-round draft pick. He has started all 98 of the games he has played in his career, including 15 last season. He made the Pro Bowl in 2021.(Azacitidine + cedazuridine) by Taiho Oncology for Chronic Myelomonocytic Leukemia (CMML): Likelihood of Approval
Smart Money Is Betting Big In VST OptionsBenazir Bhutto: A real champion of democracyScrubs had a healthy run on broadcast TV in the 2000s, airing its first seven seasons on NBC, and the last two seasons on ABC. Unfortunately, the “most realistic” medical show , which ranks as one of the best sitcoms of all time , ended on an underwhelming note with the polarizing ninth season . However, nearly a decade and a half later, fans may get to revisit this world that blended together comedy and drama seamlessly. Yesterday, it was announced that the long-discussed Scrubs reboot is finally in development , with Bill Lawrence , the original show’s creator, coming back to shepherd it, albeit not as showrunner. Now the writer/producer/director has taken to social media to defend the reboot after fans expressed concern about Scrubs returning to ABC. This all started when Lawrence, who’s been keeping audiences entertained in recent years with Apple TV+ subscription -exclusive shows like Ted Lasso and Shrinking , responded on X (formerly known as Twitter) to a fan of the original Scrubs who said he “ truly loved this show growing up but there is no reason to bring these characters back.” This fan tagged Lawrence to ask him if he’s involved in the reboot, to which Lawrence answered: Yeah, I will help. Why would you hope it doesn’t happen? Not a ton of people are working out here. The cast/crew all love each other. And if it’s great you’ll be psyched. If it’s not you won’t watch. Get on board! lol. #Scrubs While there are various reboots/revivals of popular shows from decades back that don’t end up working out, that’s not deterring Bill Lawrence from wanting to give Scrubs the same treatment. Between both providing work opportunities and the camaraderie that still exists with the actors and behind-the-scenes talent, that’s more than enough justification to move forward with the project, in his eyes. The fan followed up and told Lawrence that the ending of the Scrubs Season 8 finale, which was originally intended to be the series finale, was “beautiful,” and he was concerned whether the reboot “can recapture that magic or will it feel forced.” Lawrence told him in another X post : I hear you man. And I’m grateful you’re invested. But we will have to come up with something that makes it seem worthwhile. And hopefully we will nail it. But big fun to try. It’s our job! Lawrence then wrote up a third X post to acknowledge the concerns various fans have over Scrubs being brought back, saying that this is something worth trying to do. In his words: Guess the easy reboot sum up: I get some folks reservations the same way I get others’ excitement. Both just feel like pressure to do something cool/new/good. We’re gonna try. I imagine the world will let us know if it works. #Scrubs Per the information shared yesterday, now that Bill Lawrence has boarded the Scrubs reboot, the next step is to secure original series stars Zach Braff , Donald Faison, Sarah Chalke and John C. McGinley, who respectively play John “J.D.” Dorian, Christopher Turk, Elliot Reid and Perry Cox. Judy Reyes, who plays Carla Espinosa, also “factored into early plans for the reboot,” but now that she’s a series regular on High Potential , it’s unclear if she could participate in the reboot, too. There’s no mention about if we’ll see Ken Jenkins and Neil Flynn respectively reprise Bob Kelso and Janitor. At this point, it’s not guaranteed yet that the Scrubs reboot will make it to the airwaves, but we’ll keep you updated on the project’s progress as more news comes in. For now, you’re welcome to revisit the original with a Hulu subscription and look over our ranking of the 10 best Scrubs episodes . CINEMABLEND NEWSLETTER Your Daily Blend of Entertainment News
Alibaba: Time To Get Out Of ChinaJimmy Carter, a man of implacable faith, lived his values
ARTHEx-01 is under clinical development by ARTHEx Biotech and currently in Phase II for Myotonic Dystrophy. According to GlobalData, Phase II drugs for Myotonic Dystrophy does not have sufficient historical data to build an indication benchmark PTSR for Phase II. GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. ARTHEx-01 overview ARTHEx-01 is under development for the treatment of myotonic dystrophy type 1 (DM1), myotonic dystrophy type 2 (DM2) and congenital DM1. It acts by targeting microRNA 23b (miR-23b) which is associated with regulating the expression of MBNL protein. It is administered through intravenous ARTHEx Biotech overview ARTHEx Biotech, is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases. The company is headquartered in Spain. For a complete picture of ARTHEx-01’s drug-specific PTSR and LoA scores, This content was updated on 12 April 2024 From Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors. , the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. GlobalData’s Likelihood of Approval analytics tool dynamically assesses and predicts how likely a drug will move to the next stage in clinical development (PTSR), as well as how likely the drug will be approved (LoA). This is based on a combination of machine learning and a proprietary algorithm to process data points from various databases found on GlobalData’s .NCSOFT has been recognized for its outstanding performance in global ESG evaluations, achieving the highest rating in the domestic gaming industry for four consecutive years. In the ‘Morgan Stanley Capital International (MSCI) 2024 ESG’ assessment, NCSOFT was the only domestic gaming company to receive an AA rating. After earning an A rating in 2021, the company has maintained its AA rating for three consecutive years starting in 2022, showcasing its industry-leading status. MSCI has been conducting global ESG assessments since 1999, analyzing key issues related to environmental, social, and governance factors among publicly listed companies worldwide and assigning ratings on a seven-point scale. NCSOFT demonstrated excellent performance in areas such as data protection and risk management, transparent environmental information disclosure, and systematic grievance handling processes. Notably, the company was rated in the top 5% of the industry in information security and privacy protection. Additionally, NCSOFT is the only domestic gaming company to be included in the Dow Jones Sustainability Indices (DJSI) Asia Pacific index for two consecutive years. Since being the first domestic gaming company to be listed in the DJSI Asia Pacific index in 2023, it has continued to receive recognition for its strong ESG management performance. The DJSI is a global sustainability evaluation index published by S&P Global, one of the world's largest financial information providers, which assesses companies’ ESG performance and awards this index to the top 20% among the highest 600 companies in the Asia-Pacific region. Furthermore, in August, NCSOFT obtained an overall A rating from the Korea Corporate Governance Service (KCGS) ESG assessment for four consecutive years, earning the highest evaluation among domestic gaming companies. “This recognition reflects NCSoft's commitment to sustainable management and its achievements," said Kim Hyun-joo, head of NCSOFT's ESG Management Department. "We plan to continuously identify and actively implement ESG management initiatives that enhance our industry competitiveness in the future.”The Hitchhiker’s Guide to failing to elect a House speaker quicklyThe Hellenic Air Force plans to acquire weapons worth at least €1 bln to equip the upgraded F-16 Viper, older versions of the fighter jet, and the F-35s that Greece is set to receive by the end of the decade. This initiative aims to address a critical gap created during the years of financial crisis, when defense budgets were virtually non-existent. The Hellenic Air Force General Staff has finalized its prioritization of weapons and ammunition needs, and a comprehensive list has been submitted to the political leadership for review, according to Kathimerini sources. The air force’s weapons acquisition plan is expected to be officially announced within the first two months of 2025, when Defense Minister Nikos Dendias offers a detailed presentation of Agenda 2030 reforms for the military. However, specific details, including the number of missiles, their versions, and other technical characteristics, will remain classified, as these armaments constitute the core weaponry of the air force. The range of Hellenic Air Force purchases includes at least five different types of weapons, such as air superiority missiles, land-attack missiles, anti-ship missiles, stand-off weapons, and anti-radar systems, Kathimerini sources have informed. According to the same sources, these weapons have been cleared for Greece, with approval from US defense authorities. The Standing Committee on National Defense and Foreign Affairs has, in some cases, also granted approval. What remains to be determined is whether all the released weapons will be purchased at once or if the acquisition will be spread over the decade, depending on operational needs.